Downstream Processing of Lentiviral Vectors: Releasing Bottlenecks

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Human Gene Therapy Methods

• Publication date

  2012-07-30

• Fields of study

  Biology, Medicine, Engineering

• Identifiers
  DOI 10.1089/hgtb.2012.059PMID 22934827
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Production and purification of lentiviral vectors generated in 293T suspension cells with baculoviral vectors

  2011cited by this paper
• Highly efficient concentration of lenti- and retroviral vector preparations by membrane adsorbers and ultrafiltration

  2011cited by this paper
• Large-Scale Manufacture and Characterization of a Lentiviral Vector Produced for Clinical Ex Vivo Gene Therapy Application

  2011cited by this paper
• Large-scale production means for the manufacturing of lentiviral vectors.

  2010cited by this paper
• Purification of adenoviral vectors by combined anion exchange and gel filtration chromatography

  2009cited by this paper
• Thermosensitivity of the Reverse Transcription Process as an Inactivation Mechanism of Lentiviral Vectors

  2009cited by this paper
• From retroviral vector production to gene transfer: spontaneous inactivation is caused by loss of reverse transcription capacity

  2008cited by this paper
• Polymethacrylate monoliths for preparative and industrial separation of biomolecular assemblies.

  2008cited by this paper
• Clinical application of lentiviral vectors - concepts and practice.

  2008cited by this paper
• Scaleable purification process for gene therapy retroviral vectors

  2007influential reference
• Purification of retroviral vectors for clinical application: biological implications and technological challenges.

  2007influential reference
• Effect of osmotic pressure on the production of retroviral vectors: Enhancement in vector stability

  2006cited by this paper
• Effect of medium sugar source on the production of retroviral vectors for gene therapy

  2006cited by this paper
• Downstream processing of oncoretroviral and lentiviral gene therapy vectors.

  2006cited by this paper
• Screening anion-exchange chromatographic matrices for isolation of onco-retroviral vectors.

  2006cited by this paper
• Relationship between retroviral vector membrane and vector stability.

  2006cited by this paper
• Convective Interaction Media (CIM)--short layer monolithic chromatographic stationary phases.

  2005cited by this paper
• Downstream processing of viral vectors and vaccines

  2005cited by this paper
• Convective interaction media short monolithic columns: enabling chromatographic supports for the separation and purification of large biomolecules.

  2005cited by this paper
• Upscaling of lentiviral vector production by tangential flow filtration

  2005cited by this paper
• A novel purification strategy for retrovirus gene therapy vectors using heparin affinity chromatography.

  2005influential reference
• Evaluation of Plasmid DNA Removal from Lentiviral Vectors by Benzonase Treatment

  2004cited by this paper
• Size-Exclusion Chromatography Purification of High-Titer Vesicular Stomatitis Virus G Glycoprotein-Pseudotyped Retrovectors for Cell and Gene Therapy Applications

  2003cited by this paper
• Large-scale Purification of a Lentiviral Vector by Size Exclusion Chromatography or Mustang Q Ion Exchange Capsule

  2003cited by this paper
• The temperature stability of mouse retroviruses depends on the cholesterol levels of viral lipid shell and cellular plasma membrane.

  2003cited by this paper
• Optimized lentiviral vector production and purification procedure prevents immune response after transduction of mouse brain

  2003cited by this paper
• Continuous high-titer HIV-1 vector production

  2003cited by this paper
• Generation of a stable cell line producing high-titer self-inactivating lentiviral vectors.

  2001cited by this paper
• Packaging cell line DNA contamination of vector supernatants: implication for laboratory and clinical research.

  2001cited by this paper
• Kinetic analyses of stability of simple and complex retroviral vectors.

  2001cited by this paper
• Clinical retroviral vector production: step filtration using clinically approved filters improves titers

  2000cited by this paper
• Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector.

  1996cited by this paper
• In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector

  1996cited by this paper
• A new mass spectrometric approach to detect modifications in DNA.

  1994cited by this paper

• Enhanced lentiviral vector recovery and separation using arginine hydrochloride with CIM QA monoliths.

  2026cites this paper
• Challenges and Opportunities in Lentivirus Viral Vector Manufacturing for In Vivo Applications.

  2026cites this paper
• Streamlined purification of ADDomer nanoparticles for scalable biomanufacturing

  2025cites this paper
• Development of a robust large scale downstream processing of lentiviral vectors using tangential flow filtration

  2025cites this paper
• Digital Twin for Upstream and Downstream Integration of Virus-like Particle Manufacturing

  2025cites this paper
• Navigating the Purification Process: Maintaining the Integrity of Replication-Competent Enveloped Viruses

  2025cites this paper
• A blueprint for TFF format selection: Hollow fibers and flat sheets for ultrafiltration of AAV

  2025cites this paper
• Optimizing nuclease treatment to enhance anion exchange chromatography of HIV-derived virus-like particles.

  2025cites this paper
• Analysis of HIV-1-Based Lentiviral Vector Particle Composition by PacBio Long-Read Nucleic Acid Sequencing

  2025cites this paper
• Investigating Ultrafiltration Membranes and Operation Modes for Improved Lentiviral Vector Processing

  2025cites this paper
• Development of Lentiviral Packaging Cells and Scale Up of Production to Meet the Growing Demand in Cell and Gene Therapy.

  2025cites this paper
• Downstream Workflows for Intermediate Purification of Lentiviral Vectors Using Tangential Flow Filtration and AEX Membrane Chromatography

  2025cites this paper
• High yield sterile filtration process for highly concentrated lentiviral vectors

  2024influential citation
• Role of Microfiltration Membrane Morphology on Nanoparticle Purification to Enhance Downstream Purification of Viral Vectors.

  2024cites this paper
• Optimizing lentiviral vector formulation conditions for efficient ex vivo transduction of primary human T cells in chimeric antigen receptor T-cell manufacturing.

  2024cites this paper
• Engineering an Autonucleolytic Mammalian Suspension Host Cell Line to Reduce DNA Impurity Levels in Serum-Free Lentiviral Process Streams

  2024cites this paper
• Implementation of Novel Affinity Ligand for Lentiviral Vector Purification

  2023influential citation
• Peptide ligands targeting the vesicular stomatitis virus G (VSV‐G) protein for the affinity purification of lentivirus particles

  2023cites this paper
• The downstream bioprocess toolbox for therapeutic viral vectors.

  2023cites this paper
• Serum-free lentiviral vector production is compatible with medium-resident nuclease activity arising from adherent HEK293T host cells engineered with a nuclease-encoding transgene

  2023influential citation
• Time‐dependent sorption behavior of lentiviral vectors during anion‐exchange chromatography

  2023cites this paper
• Downstream process design for Gag HIV‐1 based virus‐like particles

  2023influential citation
• Single-Pass Tangential Flow Filtration (SPTFF) of Nanoparticles: Achieving Sustainable Operation with Dilute Colloidal Suspensions for Gene Therapy Applications

  2023cites this paper
• Removal of chromatin by salt‐tolerant endonucleases for production of recombinant measles virus

  2023cites this paper
• Steric Exclusion Chromatography for Purification of Biomolecules—A Review

  2023cites this paper
• Purification of recombinant vesicular stomatitis virus-based HIV vaccine candidate.

  2023cites this paper
• Anion exchange chromatography-based platform for the scalable purification of extracellular vesicles derived from human mesenchymal stromal cells

  2023cites this paper
• Evaluation of Host Cell Impurity Effects on the Performance of Sterile Filtration Processes for Therapeutic Viruses

  2022cites this paper
• Single-step rapid chromatographic purification and characterization of clinical stage oncolytic VSV-GP

  2022cites this paper
• Evaluation of lentiviral vector stability and development of ion exchange purification processes

  2022cites this paper
• Cancer Gene Therapy: Development and Production of Lentiviral Vectors for Gene Therapy.

  2022cites this paper
• Steric exclusion chromatography of lentiviral vectors using hydrophilic cellulose membranes.

  2022cites this paper
• Clinical grade lentiviral vector purification and quality control requirements.

  2022cites this paper
• Boosting antitumor response with PSMA-targeted immunomodulatory VLPs, harboring costimulatory TNFSF ligands and GM-CSF cytokine

  2022cites this paper
• A scalable, integrated downstream process for production of a recombinant measles virus-vectored vaccine.

  2022cites this paper
• 3D-printed ordered bed structures for chromatographic purification of enveloped and non-enveloped viral particles

  2021cites this paper
• Production and Use of Gesicles for Nucleic Acid Delivery

  2021cites this paper
• Scaled preparation of extracellular vesicles from conditioned media.

  2021cites this paper
• Enhancing the purification of Lentiviral vectors for clinical applications

  2021cites this paper
• Breaching the Delivery Barrier: Chemical and Physical Airway Epithelium Disruption Strategies for Enhancing Lentiviral-Mediated Gene Therapy

  2021cites this paper
• Effective Transduction of Brain Neurons with Lentiviral Vectors Purified via Ion-Exchange Chromatography

  2021cites this paper
• Lentiviral Vector Bioprocessing

  2021influential citation
• Integrated development of enzymatic DNA digestion and membrane chromatography processes for the purification of therapeutic adenoviruses

  2021cites this paper
• Advances in Lentivirus Purification

  2020cites this paper
• Opportunities to debottleneck the downstream processing of the oncolytic measles virus

  2020cites this paper
• A Flow-Through Chromatographic Strategy for Hepatitis C Virus-Like Particles Purification

  2020cites this paper
• Development of Large-Scale Downstream Processing for Lentiviral Vectors

  2020cites this paper
• Production of high‐titer transmission‐defective RNA virus‐based episomal vector using tangential flow filtration

  2020cites this paper
• The COVID-19 Vaccine Race: Challenges and Opportunities in Vaccine Formulation

  2020cites this paper
• Large-Scale Production of Lentiviral Vectors: Current Perspectives and Challenges

  2020cites this paper
• Laboratory-Scale Lentiviral Vector Production and Purification for Enhanced Ex Vivo and In Vivo Genetic Engineering

  2020cites this paper
• Lentiviral vector bioprocess economics for cell and gene therapy commercialization

  2020cites this paper
• Tangential Flow Filtration for the Concentration of Oncolytic Measles Virus: The Influence of Filter Properties and the Cell Culture Medium

  2019influential citation
• Development of lentiviral airway gene therapy aerosol delivery techniques for cystic fibrosis

  2019cites this paper
• Development of Isoporous Microslit Silicon Nitride Membranes for Sterile Filtration Applications.

  2019cites this paper
• Affinity chromatography for vaccines manufacturing: Finally ready for prime time?

  2019cites this paper
• Pre-proof Lentiviral Vector Purification Using Nanofiber Ion Exchange Chromatography

  2019cites this paper
• Lentiviral Vector Purification Using Nanofiber Ion-Exchange Chromatography

  2019cites this paper
• Toward a Scalable Purification Protocol of GaLV-TR-Pseudotyped Lentiviral Vectors

  2019cites this paper
• Real-time transfer of lentiviral particles by producer cells using an engineered coculture system

  2019cites this paper
• Future Science Group

  2019cites this paper
• Production of CAR T-cells by GMP-grade lentiviral vectors: latest advances and future prospects

  2019cites this paper
• Purification of New Biologicals Using Membrane-Based Processes

  2019cites this paper
• Production of Lentiviral Vectors Using Suspension Cells Grown in Serum-free Media

  2019cites this paper
• Use of Enzymes in the Downstream Processing of Biopharmaceuticals

  2019cites this paper
• Lentiviral Vector Purification Using Genetically Encoded Biotin Mimic in Packaging Cell

  2018cites this paper
• Gene Therapy.

  2018cites this paper
• Lentiviral Vectors Come of Age? Hurdles and Challenges in Scaling Up Manufacture

  2018cites this paper
• New Bioprocessing Strategies: Development and Manufacturing of Recombinant Antibodies and Proteins

  2018cites this paper
• Challenges and progress in lentiviral vector bioprocessing

  2018cites this paper
• Scalable Lentiviral Vector Production Using Stable HEK293SF Producer Cell Lines

  2017cites this paper
• Separation of HIV-1 gag virus-like particles from vesicular particles impurities by hydroxyl-functionalized monoliths.

  2017cites this paper
• Small synthetic ligands for the enrichment of viral particles pseudotyped with amphotropic murine leukemia virus envelope.

  2016cites this paper
• The role of high mobility nucleosomal binding protein (Hmgn2) in undifferentiated mouse epiblast carcinoma stem cells

  2016cites this paper
• Magnetic purification of antibodies

  2016cites this paper
• PURIFICATION AND RECOVERY OF INFECTIOUS VIRUS PARTICLES USING OSMOLYTE FLOCCULATION

  2016influential citation
• Process development of lentiviral vector expression, purification and formulation for gene therapy applications

  2016influential citation
• Retroviral particles are effectively purified on an affinity matrix containing peptides selected by phage‐display

  2016cites this paper
• Improved virus purification processes for vaccines and gene therapy

  2015cites this paper
• Development of EV71 virus-like particle purification processes.

  2015cites this paper
• Improving downstream processing for viral vectors and viral vaccines

  2015cites this paper
• Improving the downstream processing of vaccine and gene therapy vectors with continuous chromatography

  2015cites this paper
• Methacrylate monolith chromatography as a tool for waterborne virus removal.

  2015cites this paper
• A scalable method to concentrate lentiviral vectors pseudotyped with measles virus glycoproteins

  2015cites this paper
• Downstream processing and chromatography based analytical methods for production of vaccines, gene therapy vectors, and bacteriophages

  2015influential citation
• Monoliths in Bioprocess Technology

  2015cites this paper
• Evaluation of Novel Large Cut-Off Ultrafiltration Membranes for Adenovirus Serotype 5 (Ad5) Concentration

  2014cites this paper
• A flow-through chromatography process for influenza A and B virus purification.

  2014cites this paper
• Concentration and purification of enterovirus 71 using a weak anion-exchange monolithic column

  2014cites this paper
• Purification of complex biopharmaceuticals with new processes, advanced analytics and computer-aided process design tools

  2013cites this paper
• Lentiviral Vector-Mediated Gene Transfer and Applications in the Field of the Respiratory Epithelium

  2013cites this paper
• Integration-specific In Vitro Evaluation of Lentivirally Transduced Rhesus CD34+ Cells Correlates With In Vivo Vector Copy Number

  2013cites this paper
• Integration-specific In Vitro Evaluation of Lentivirally Transduced Rhesus CD34+ Cells Correlates With In Vivo Vector Copy Number.

  2013cites this paper
• Emerging technologies for the integration and intensification of downstream bioprocesses

  2013cites this paper
• 21-X8 Final report

  year unknowncites this paper